|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.77 USD | -0.17% |
|
-6.59% | -16.17% |
| Market Cap | 959B 10B 8.79B 8.19B 7.52B 14.12B 14.3B 97.22B 37.95B 473B 37.53B 36.72B 1,637B | P/E 2027 * |
25.5x | P/E 2028 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 927B 9.67B 8.5B 7.92B 7.27B 13.65B 13.83B 94.02B 36.7B 458B 36.29B 35.51B 1,583B | EV / Sales 2027 * |
2.64x | EV / Sales 2028 * | 2.31x |
| Free-Float |
70.08% | Yield 2027 * |
0.66% | Yield 2028 * | 0.73% |
Last Transcript: Dr. Reddy's Laboratories Limited
| 1 day | -0.17% | ||
| 1 week | -6.59% | ||
| Current month | -18.77% | ||
| 1 month | -23.47% | ||
| 3 months | -13.90% | ||
| 6 months | -14.59% | ||
| Current year | -16.17% |
| 1 week | 11.36 |  | 12.61 |
| 1 month | 11.36 | | 15.13 |
| Current year | 11.36 | | 15.67 |
| 1 year | 11.36 | | 15.67 |
| 3 years | 11.36 | | 16.89 |
| 5 years | 9.58 | | 16.89 |
| 10 years | 5.63 | | 16.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 59 | 2019-06-30 |
| Director of Finance/CFO | - | 2024-07-31 | |
Sanjay Sharma
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 2014-05-12 | |
Gunupati Prasad
CHM | Chairman | 65 | 2013-04-01 |
Leo Puri
BRD | Director/Board Member | 65 | 2018-10-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | -6.59% | - | - | 9.97B | |
| +0.13% | +1.56% | +47.35% | +164.01% | 1,067B | |
| +0.97% | +5.10% | +58.02% | +53.98% | 635B | |
| -0.94% | +0.95% | +35.02% | +81.05% | 458B | |
| +1.41% | +7.75% | +38.93% | +32.88% | 347B | |
| +1.28% | +2.82% | +38.42% | +43.21% | 295B | |
| +1.72% | +2.33% | +19.31% | +20.79% | 262B | |
| +1.84% | -1.03% | -27.78% | -38.45% | 216B | |
| +0.06% | +2.72% | +22.73% | +59.97% | 203B | |
| +0.94% | -2.80% | +12.32% | +69.09% | 161B | |
| Average | +0.70% | +1.33% | +27.15% | +54.06% | 404.83B | |
| Weighted average by Cap. | +0.54% | +1.95% | +36.75% | +79.84% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 351B 3.66B 3.22B 3B 2.75B 5.17B 5.24B 35.58B 13.89B 173B 13.73B 13.44B 599B | 393B 4.1B 3.61B 3.36B 3.09B 5.79B 5.87B 39.9B 15.57B 194B 15.4B 15.07B 672B |
| Net income | 37.18B 388M 341M 318M 292M 548M 555M 3.77B 1.47B 18.36B 1.46B 1.42B 63.49B | 49.48B 516M 454M 423M 388M 729M 738M 5.02B 1.96B 24.43B 1.94B 1.89B 84.49B |
| Net Debt | -31.58B -329M -290M -270M -248M -465M -471M -3.2B -1.25B -15.59B -1.24B -1.21B -53.93B | -51.62B -538M -473M -441M -405M -760M -770M -5.23B -2.04B -25.49B -2.02B -1.98B -88.15B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | US$11.77 | -0.17% | 3,620,643 |
| 26-07-24 | US$11.79 | -0.08% | 3,229,739 |
| 26-07-23 | US$11.80 | +3.69% | 7,332,864 |
| 26-07-22 | US$11.38 | -9.39% | 4,326,646 |
| 26-07-21 | US$12.56 | +0.24% | 1,440,026 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DRREDDY Stock
- RDY Stock
Select your edition
All financial news and data tailored to specific country editions
